Skip to content

Testosterone levels, fat free mass, increases differ according to HIV drugs taken

Rosiglitazone does not improve fat loss in patients taking HIV treatment

Antiretroviral therapy carries same risk of ischaemic heart disease as 1-4 cigarettes a day, Danish study shows

Polyalkylimide gel safe and effective for treatment of facial lipoatrophy

Rosiglitazone analysis sparks safety controversy

Blood disorders common in antiretroviral-exposed infants

HIV/hepatitis C coinfected may have less risk of lipodystrophy and diabetes

Pubic lipomas: a new manifestation of lipodystrophy?

Mitochondrial toxicity can be increased by genetic factors